The 2021 ESC/EACTS guidelines recommend all* sAS patients with severe aortic stenosis are referred to the Heart Team1

The new 2021 ESC/EACTS VHD guidelines recommend that all* symptomatic patients with severe aortic stenosis (sAS) are referred to the Heart Team for a treatment evaluation. The Heart Team will assess multiple patient factors, including their age, their values and preferences, when making the final decision between TAVI and SAVR.1

* With treatment indication. 1

The Heart Team referral is the first step towards an optimal treatment decision

It is important that your patients with severe aortic stenosis (sAS) are provided the most appropriate treatment. The 2021 ESC/EACTS VHD guidelines recommend that the Heart Team evaluate treatment options using an individualised approach for every patient. Underpinning this, is the vital collateral information provided by their referring Cardiologist.1

Putting patients at the centre of the treatment decision

  • The 2021 ESC/EACTS VHD guidelines have emphasised the importance to incorporate patients’ values and preferences in the decision between TAVI or SAVR.1
  • A systematic review conducted in 2016 of patient values and preferences on aortic valve replacement therapy2 found great variability.2
  • The 2021 guidelines have taken the need to tailor care into account by advising that the Heart Team recommendation is discussed with each individual patient to allow them to make a fully informed decision.1
Our infographic outlines the new referral process and evaluation considerations that could now influence your final treatment decision1

Articles similar to this

2021 ESC/EACTS Treatment Guidelines

Explore the latest updates in aortic stenosis management and see the impact this may have on your referral decisions.

Diagnosing Aortic Stenosis patients

It can be challenging confirming the AS severity and finding the optimal time to refer for further treatment.

Check out our latest articles

https://1acvlp2qw4ys2fyruq3xmc93-wpengine.netdna-ssl.com/wp-content/uploads/2022/04/73031724-001_GettyImages-1294678917_630x700px@72dpi.jpg
Challenges in treating patients with asymptomatic severe aortic stenosis (sAS)
May 2022 Read more
C-ARTICLE-THUMBNAIL
Important considerations for the referral of patients with severe aortic stenosis
Jan 2022 Read more

Stay informed with our newsletter

Our monthly updates provide you the latest developments in TAVI and aortic stenosis.     Read more

References

  • 1VahanianA,etal.EurHeartJ.2021;00:1-72
  • 2LytvynL,etal.BMJOpen.2016;6:e014327
Content relating to Tavi.today is intended for healthcare professionals. Click OK to confirm you are a healthcare professional and proceed.
Skip to content